Compile Data Set for Download or QSAR
Report error Found 29 Enz. Inhib. hit(s) with all data for entry = 12943
TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743413(US20250163067, Compound IV-14)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743427(US20250163067, Compound IV-30)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743426(US20250163067, Compound IV-29)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743425(US20250163067, Compound IV-28)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743424(US20250163067, Compound IV-26)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743423(US20250163067, Compound IV-24)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743422(US20250163067, Compound IV-23)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743421(US20250163067, Compound IV-22)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743420(US20250163067, Compound IV-21)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743419(US20250163067, Compound IV-20)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743418(US20250163067, Compound IV-19)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743417(US20250163067, Compound IV-18)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743416(US20250163067, Compound IV-17)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743415(US20250163067, Compound IV-16)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743414(US20250163067, Compound IV-15)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743399(US20250163067, Compound I-4)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743412(US20250163067, Compound IV-13)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743411(US20250163067, Compound IV-12)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743410(US20250163067, Compound IV-11)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743409(US20250163067, Compound IV-10)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743408(US20250163067, Compound IV-9)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743407(US20250163067, Compound IV-8)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743406(US20250163067, Compound IV-7)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743405(US20250163067, Compound IV-6)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743404(US20250163067, Compound IV-5)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743403(US20250163067, Compound IV-4)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743402(US20250163067, Compound IV-3)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743401(US20250163067, Compound IV-2)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent

TargetHistone-lysine N-methyltransferase NSD2(Human)
K36 Therapeutics

US Patent
LigandPNGBDBM743400(US20250163067, Compound IV-1)
Affinity DataIC50: 1.00E+3nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/20/2025
Entry Details
Go to US Patent